SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schwarz, E. R.
Right arrow Articles by Uretsky, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarz, E. R.
Right arrow Articles by Uretsky, B. F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Monocyte Chemoattractant Protein 1-Induced Monocyte Infiltration Produces Angiogenesis but Not Arteriogenesis in Chronically Infarcted Myocardium

Ernst R. Schwarz, MD, PhD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany and Division of Cardiology, The University of Texas Medical Branch, Galveston, TX

Dennis A. Meven, MD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany

Nasir Z. Sulemanjee, MD

Division of Cardiology, The University of Texas Medical Branch, Galveston, TX

Philipp H. Kersting, MD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany

Tanja Tussing, MD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany

Erik C. Skobel, MD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany

Peter Hanrath, MD

Department of Cardiology, Rheinisch-Westfaelisch Technische Hochschule University Hospital Aachen, Germany

Barry F. Uretsky, MD

Division of Cardiology, The University of Texas Medical Branch, Galveston, TX

Background: Monocyte chemoattractant protein 1 (MCP-1) stimulates the invasion of monocytes into ischemic tissue with concomitant adhesion to endothelial cells. Monocyte stimulation has been shown to be involved in the induction of arteriogenesis, which is the development of functional arterioles resulting in improvement of perfusion. However, angiogenesis (newly developed capillaries contribute to improved tissue perfusion) in several models has not resulted in any improvement in blood flow.

Objective: The effects of MCP-1 on potential angiogenesis and arteriogenesis as well as changes in left ventricular function were tested in a chronic infarct model in rat hearts.

Methods: Anesthetized rats were subjected to open-chest ligation of the left coronary artery with subsequent myocardial infarction. After 6 weeks, animals were randomized to receive either MCP-1 (3 µL in 0.15 mL NaCl, group 1, n = 9) or saline (0.15 mL, group 2, n = 9), which was injected into the myocardium at the border zones of the infarcts. For assessment of left ventricular dimensions and global cardiac function, transthoracic two-dimensional echocardiography was performed at baseline, 6 weeks after myocardial infarction, and 4 weeks after MCP-1 or saline injection, by use of a 12-MHz pediatric transducer. For light microscopic analysis, myocardial tissue was stained with Elastica-van-Giesson and von Willebrand factor for blood vessels and endothelial cells, respectively. In a subset of animals, hearts were excised 24 hours after MCP-1 administration (n = 4) or saline administration (n = 4) for assessment of monocyte infiltration by immunohistologic staining of the CD31 antigen.

Results: Left ventricular dimensions and ejection fraction changed after coronary occlusion (from 60.4% ± 2.85% to 24.8% ± 5.01% ejection fraction in group 1, and from 58.4% ±2.06% to 26.3% ± 4.3% ejection fraction in group 2 at 6 weeks, P < .005) without any further change 4 weeks after treatment (ejection fraction in group 1, 26.3% ± 2.7%, ejection fraction in group 2, 25.0% ± 5.18%). The MCP-1 group resulted in 390.6 ± 10.36 endothelial cells compared with 285.2 ± 13.56 in group 2 (P < .005) at the injection site. Monocyte infiltration was observed at the MCP-1 injection site with an increase in capillary growth (angiogenesis). However, there was no difference in the number of arteriolar structures between animals treated with MCP-1 and saline animals (group 1, 19.0 ± 1.52 vs group 2,16.4 ± 0.68, P > .05).

Conclusion: A single intramyocardial injection of MCP-1 into the infarct border zone resulted in neo-angiogenesis and monocyte infiltration but not arteriogenesis in the rat heart. There was no functional change of chronically infarcted myocardium in the present model.

Key Words: MCP-1 • myocardial infarction • angiogenesis • arteriogenesis • rats

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 9, No. 4, 279-289 (2004)
DOI: 10.1177/107424840400900408


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Shantsila and G. Y.H. Lip
Monocytes in Acute Coronary Syndromes
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1433 - 1438.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Shantsila and G. Y.H. Lip
Monocyte Diversity in Myocardial Infarction.
J. Am. Coll. Cardiol., July 7, 2009; 54(2): 139 - 142.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. J. Capoccia, A. D. Gregory, and D. C. Link
Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion
J. Leukoc. Biol., September 1, 2008; 84(3): 760 - 768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Anghelina, P. Krishnan, L. Moldovan, and N. I. Moldovan
Monocytes/Macrophages Cooperate with Progenitor Cells during Neovascularization and Tissue Repair: Conversion of Cell Columns into Fibrovascular Bundles
Am. J. Pathol., February 1, 2006; 168(2): 529 - 541.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. R. Small, P. W. F. Hadoke, I. Sharif, A. R. Dover, D. Armour, C. J. Kenyon, G. A. Gray, and B. R. Walker
Preventing local regeneration of glucocorticoids by 11{beta}-hydroxysteroid dehydrogenase type 1 enhances angiogenesis
PNAS, August 23, 2005; 102(34): 12165 - 12170.
[Abstract] [Full Text] [PDF]



Advertisement